Critical Outcome Technologies has received a patent for its advanced oncology drug candidate, from the US Patent and Trademark Office. The patent covers the synergistic effects of combination therapies containing COTI-2 and members of ...
Tags: oncology drug, COTI-2, anti cancer agents
The European Commission (EC) has granted orphan drug designation to Sunesis Pharmaceuticals' Vosaroxin drug. Vosaroxin is a first-in-class anti-cancer quinolone derivative, (AQD), used for the treatment of acute myeloid leukemia (AML). ...
Tags: vosaroxin, AQD, AML, anti-cancer quinolone derivative
Saladax Biomedical has signed a diagnostic agreement with Eilaf Pharma for My5-FU diagnostic test in Egypt and throughout the Middle East North African (MENA) region. The test will measure the levels of an anti-cancer drug, ...
Tags: My5-FU diagnostic test, medical research, medical test
Janssen Biotech, a Johnson & Johnson company, has executed a license and development agreement for an investigational anti-cancer agent, daratumumab (HuMax-CD38), with Genmab. Daratumumab is a human CD38 monoclonal antibody which is ...
Tags: Daratumumab License, license and development agreement, anti-cancer
TTY Biopharm Co.,Ltd.,a major pharmaceutical maker in Taiwan,recently inaugurated a drug factory in Suzhou,Jiangsu Province of China,operated by TTY`s Chinese subsidiary TOT Biopharm Co.,Ltd. At a cost of about US$100 million,the factory ...
Tags: TTY Biopharm, drug factory, anti-cancer drug injections, Suzhou
Advanced Cancer Therapeutics (ACT) has received Phase I small business innovative research (SBIR) grant of $158,000 from the National Cancer Institute of the National Institutes of Health (NIH) to support the development of an anti cancer ...
Tags: ACT, SBIR Grant, anti cancer drug, Anticancer Drug
Clinical stage biopharmaceutical company, Tocagen, has entered into a partnership agreement with MRI Interventions and Brainlab. Under the collaboration, Tocagen will use MRI Interventions' ClearPoint neuro intervention system at selected ...
Results are interesting for treating skin cancer(melanoma)and nervous system tumors,known as gliomas. "Promising results"-Pablo Botella,researcher at the Institute of Chemical Technology of Valencia. Spanish researchers have ...
CZ BioMed has signed a worldwide licensing agreement with South Texas Technology Management (STTM) on behalf of The University of Texas Health Science Center San Antonio and The University of Texas System Board of Regents for exclusive use ...